• Acetylcholine Chloride in Gut-Brain Cholinergic Pathway Rese

  2026-08-05

  Acetylcholine Chloride empowers high-fidelity modeling of gut-brain cholinergic circuits, enabling translational breakthroughs in neuromuscular and neurogastroenterology research. Advanced workflows, troubleshooting guidance, and protocol refinements help researchers decode microbiota-brain interactions and optimize experimental reproducibility.

• Branched Lipids Enhance mRNA and RNP Delivery for Gene Editi

  2026-08-04

  The reference study introduces branched endosomal disruptor (BEND) lipids that markedly improve the cytosolic delivery of mRNA and CRISPR-Cas9 RNP complexes. This innovation addresses key bottlenecks in hepatic gene editing and T cell engineering by optimizing endosomal escape, with broad implications for the clinical translation of mRNA therapeutics.

• Sunitinib: Multi-Targeted RTK Inhibitor for RCC Research Wor

  2026-08-04

  Leverage Sunitinib’s multi-pathway RTK inhibition to dissect tumor angiogenesis, drive apoptosis, and overcome resistance in renal cell carcinoma models. Explore practical protocol refinements, combination strategies, and troubleshooting methods that accelerate translational research and maximize the value of APExBIO’s Sunitinib in cutting-edge oncology studies.

• ETS1 Modulates Mitophagy via SENP2/HSPA8/FUNDC1 in BPD Model

  2026-08-03

  This study reveals that the transcription factor ETS1 mitigates bronchopulmonary dysplasia (BPD) by inhibiting mitochondrial damage-induced autophagy via the SENP2/HSPA8/FUNDC1 axis. These mechanistic insights highlight ETS1 as a regulator of mitophagy with potential impact on targeted BPD interventions.

• GDC-0941: Mechanistic Leverage and Strategic Value in PI3K I

  2026-08-03

  This thought-leadership article presents a comprehensive analysis of GDC-0941, a highly selective PI3K inhibitor, emphasizing the mechanistic underpinnings, translational research imperatives, and strategic guidance for oncology investigators. By integrating recent evidence, competitive perspectives, and future outlooks, the article provides actionable insights for designing robust experiments and advancing from bench to bedside.

• Adefovir (GS-0393): Optimized Workflows for HBV & Transporte

  2026-08-02

  Adefovir (GS-0393) is a precision HBV DNA polymerase inhibitor and OAT1 probe, offering exceptional selectivity and reproducibility for virology and transporter studies. This article delivers actionable workflow enhancements, protocol parameters, and troubleshooting tips—translating recent research insights into practical lab success.

• Targeting SCUBE3: Dual Inhibition of Oncogenic Signaling and

  2026-08-01

  This study reveals secreted SCUBE3 as a critical facilitator of tumor growth, therapy resistance, and immune evasion, and demonstrates that antibody-mediated targeting of SCUBE3 disrupts these processes. The work provides new mechanistic insight into pan-cancer therapeutic strategies, particularly relevant for researchers investigating EGFR signaling and tumor microenvironment modulation.

• Anlotinib Hydrochloride: Redefining Multi-Targeted Angiogene

  2026-07-31

  This thought-leadership article dissects the mechanistic, experimental, and translational advantages of Anlotinib hydrochloride, a next-generation multi-target tyrosine kinase inhibitor. Drawing from landmark studies and expert protocols, it offers actionable guidance for cancer researchers seeking robust, reproducible inhibition of tumor angiogenesis. With strategic insights and a proven product supplied by APExBIO, this article charts new territory for translational teams aiming to accelerate anti-angiogenic drug discovery.

• EZ Cap™ Mouse IL-12 mRNA (m1Ψ): Engineered Cytokine mRNA for

  2026-07-31

  EZ Cap™ Mouse IL-12 mRNA (m1Ψ) provides a stabilized, low-immunogenicity mRNA encoding mouse Interleukin-12, enabling precise immune system activation for research. Its Cap 1 structure and m1Ψ modification enhance stability and translation, supporting advanced studies in cytokine-driven immunotherapy and gene expression.

• Alisol A Regulates Cholesterol and Autophagy in Vascular Cog

  2026-07-30

  This study demonstrates that Alisol A ameliorates vascular cognitive impairment by activating the AMPK/NAMPT/SIRT1 axis, restoring cholesterol homeostasis, and promoting mitophagy. The findings highlight NAMPT as a central mediator and suggest new therapeutic strategies for atherosclerosis-related cognitive decline.

• Sunitinib in Translational Oncology: Mechanisms and Strategy

  2026-07-30

  This thought-leadership article explores Sunitinib as a multi-targeted receptor tyrosine kinase inhibitor, focusing on its mechanistic role in cancer biology, strategic applications in translational research, and actionable guidance for harnessing its potential in complex tumor models—especially those characterized by ATRX deficiency. Drawing from recent evidence and advanced protocols, we bridge mechanistic insight with experimental and translational imperatives, offering a roadmap for researchers aiming to optimize anti-angiogenic and apoptosis-driven therapeutic strategies.

• RepSox ALK5 Inhibitor: Advancing iPSC Platelet Differentiati

  2026-07-29

  RepSox, a potent and selective ALK5 inhibitor, enables high-efficiency, cost-effective differentiation of platelets from human iPSCs by modulating TGF-β signaling. This article demystifies experimental workflows, protocol enhancements, and troubleshooting strategies that make RepSox indispensable for stem cell and translational research.

• Sulfo-NHS-LC-Biotin: Practical Guide for Cell Surface Biotin

  2026-07-29

  Sulfo-NHS-LC-Biotin enables selective, covalent labeling of primary amines on proteins, particularly for cell surface biotinylation in aqueous conditions. It should be used where irreversible, extracellular biotin tagging is required and is not appropriate for reversible or intracellular workflows.

• DiscoveryProbe FDA-approved Drug Library: Advanced Screening

  2026-07-28

  The DiscoveryProbe FDA-approved Drug Library empowers researchers to rapidly profile 2,320 clinically-validated compounds for drug repositioning, mechanistic screening, and high-content assays. This article details optimized protocols, innovative single-cell imaging strategies, and troubleshooting tips that unlock reproducible, translational insights in both cancer and neurodegenerative disease research.

• Sodium Ascorbate in Cancer Research: From ROS Induction to T

  2026-07-28

  Sodium Ascorbate, a mineral salt of ascorbic acid, offers a potent and bioavailable approach to drive intracellular ROS and induce necrotic tumor cell death, especially in glioblastoma models. This article translates core mechanistic insights and workflow best practices into actionable guidance for oncology research teams seeking reliable, high-purity reagents.

7980 records 3/532 page Previous Next 12345 下5页 Last page